Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Amgen Files with ITC Against Roche's Importation of peg-EPO.


THOUSAND OAKS Thousand Oaks, residential city (1990 pop. 104,352), Ventura co., S Calif., in a farm area; inc. 1964. Avocados, citrus, vegetables, strawberries, and nursery products are grown. , Calif. -- Amgen (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:AMGN), the world's largest biotechnology company, today issued the following statement:

Amgen filed a complaint with the U.S. International Trade Commission (ITC ITC (Brit) n abbr (= Independent Television Commission) → Fernseh-Aufsichtsgremium

ITC n abbr (BRIT) (= Independent Television Commission) →
) in Washington, D.C. requesting that the ITC institute an investigation of Roche's importation of pegylated recombinant human erythropoietin erythropoietin /eryth·ro·poi·e·tin/ (-poi´e-tin) a glycoprotein hormone secreted by the kidney in the adult and by the liver in the fetus, which acts on stem cells of the bone marrow to stimulate red blood cell production  (peg-EPO) into the U.S. Amgen believes that importation of peg-EPO is unlawful because peg-EPO, and the method of its manufacture are covered by Amgen's EPO EPO

see erythropoietin.

EPO Erythropoietin, see there
 patents. Amgen is asking the ITC to issue a permanent exclusion order that would prohibit importation of peg-EPO into the United States. Amgen anticipates the ITC will decide whether to institute a formal investigation within 30 days of today's filing.

Amgen is one of the pioneers in helping develop and build the biotechnology industry in the United States -- a biotechnology industry unparalleled anywhere in the world. Amgen is proud of the significant investment it has made in research, development, and manufacturing in the United States and the innovative therapies it has brought to patients. Amgen is committed to cooperating with the ITC to protect this domestic industry from unlawfully imported products.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 11, 2006
Words:184
Previous Article:Secretary Victoria Bradshaw of the California Labor & Workforce Development Agency Attends BIO 2006.
Next Article:Make Tax Day Count in Your Favor -- Win the Mega Millions Jackpot Now at $189,000,000.
Topics:



Related Articles
ANOTHER BIG DAY; LEGAL WIN BOOSTS AMGEN STOCK.
AMGEN FILES PATENT INFRINGEMENT SUIT.
AMGEN GETS PATENT FOR PROTEIN TO FIGHT DIALYSIS ANEMIA.
AMGEN SUES OVER EPOGEN THREE UNITS OF ROCHE ACCUSED OF PATENT INFRINGEMENT.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles